Crossmark

cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation

Crossref DOI link: https://doi.org/10.1007/s00401-019-01987-0

Published Online: 2019-03-08

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ellison, David W.

Hawkins, Cynthia

Jones, David T. W.

Onar-Thomas, Arzu

Pfister, Stefan M.

Reifenberger, Guido

Louis, David N.
License Information

Text and Data Mining valid from 2019-03-08
More Information

Article History

Received: 6 February 2019

Revised: 2 March 2019

Accepted: 4 March 2019

First Online: 8 March 2019